HIAHX Holdings — Hartford Healthcare Hls Fund
All 79 reported holdings of Hartford Healthcare Hls Fund (HIAHX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 12.47% | $14.01M |
| Johnson & Johnson | 6.63% | $7.44M |
| Merck & Co Inc | 6.60% | $7.41M |
| UnitedHealth Group Inc | 4.72% | $5.30M |
| AbbVie Inc | 3.43% | $3.85M |
| Intuitive Surgical Inc | 2.99% | $3.36M |
| Elevance Health Inc | 2.96% | $3.32M |
| CVS Health Corp | 2.93% | $3.29M |
| Vertex Pharmaceuticals Inc | 2.69% | $3.02M |
| Danaher Corp | 2.65% | $2.98M |
| Edwards Lifesciences Corp | 2.42% | $2.72M |
| Abbott Laboratories | 2.10% | $2.36M |
| Cencora Inc | 2.07% | $2.32M |
| Cardinal Health Inc | 1.81% | $2.04M |
| Thermo Fisher Scientific Inc | 1.64% | $1.84M |
| HCA Healthcare Inc | 1.60% | $1.80M |
| Regeneron Pharmaceuticals Inc | 1.52% | $1.71M |
| Biogen Inc | 1.41% | $1.58M |
| Agilent Technologies Inc | 1.36% | $1.53M |
| Gsk PLC | 1.21% | $1.35M |
| Boston Scientific Corp | 1.19% | $1.33M |
| Stryker Corp | 1.17% | $1.32M |
| Centene Corp | 1.16% | $1.31M |
| Medtronic PLC | 1.02% | $1.14M |
| United Therapeutics Corp | 0.96% | $1.07M |
| Incyte Corp | 0.94% | $1.05M |
| Dexcom Inc | 0.91% | $1.03M |
| Argenx SE | 0.83% | $937.98K |
| Ucb SA | 0.80% | $895.72K |
| Ionis Pharmaceuticals Inc | 0.79% | $890.98K |
| Steris PLC | 0.76% | $851.33K |
| Ascendis Pharma A/S | 0.76% | $851.10K |
| Madrigal Pharmaceuticals Inc | 0.74% | $827.44K |
| Cytokinetics Inc | 0.73% | $822.51K |
| PTC Therapeutics Inc | 0.71% | $800.77K |
| Alnylam Pharmaceuticals Inc | 0.70% | $791.41K |
| Revolution Medicines Inc | 0.70% | $782.27K |
| Elanco Animal Health Inc | 0.68% | $763.01K |
| Bristol-Myers Squibb Co | 0.66% | $738.23K |
| Fixed Income Clearing Corp. | 0.65% | $734.43K |
| Protagonist Therapeutics Inc | 0.63% | $713.17K |
| Arcus Biosciences Inc | 0.62% | $693.46K |
| AstraZeneca PLC | 0.61% | $690.79K |
| Galderma Group AG | 0.59% | $663.24K |
| Dianthus Therapeutics Inc | 0.57% | $644.73K |
| Kymera Therapeutics Inc | 0.56% | $624.72K |
| Amgen Inc | 0.55% | $621.40K |
| Bridgebio Pharma Inc | 0.55% | $618.11K |
| Pharvaris NV | 0.54% | $607.02K |
| Encompass Health Corp | 0.53% | $592.03K |
| Disc Medicine Inc | 0.51% | $576.86K |
| Icon PLC | 0.51% | $570.12K |
| Adaptive Biotechnologies Corp | 0.49% | $548.48K |
| Structure Therapeutics Inc | 0.48% | $543.84K |
| Scholar Rock Holding Corp | 0.48% | $537.96K |
| HeartFlow Inc | 0.47% | $527.80K |
| Mirum Pharmaceuticals Inc | 0.46% | $519.44K |
| Alignment Healthcare Inc | 0.45% | $503.22K |
| Immunocore Holdings PLC | 0.44% | $489.84K |
| Option Care Health Inc | 0.43% | $484.32K |
| Vaxcyte Inc | 0.43% | $480.85K |
| Celldex Therapeutics Inc | 0.43% | $479.86K |
| Qiagen NV | 0.41% | $464.12K |
| State Street Global Advisors | 0.38% | $431.64K |
| Kailera Therapeutics Inc | 0.38% | $426.32K |
| CG oncology Inc | 0.38% | $422.18K |
| Trevi Therapeutics Inc | 0.36% | $408.21K |
| Acadia Healthcare Co Inc | 0.34% | $384.75K |
| Stoke Therapeutics Inc | 0.32% | $354.68K |
| Immunome Inc | 0.31% | $351.52K |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.30% | $338.30K |
| Definium Therapeutics Inc | 0.30% | $333.98K |
| Inspire Medical Systems Inc | 0.30% | $331.54K |
| GenFleet Therapeutics Shanghai Inc | 0.28% | $313.66K |
| Crinetics Pharmaceuticals Inc | 0.23% | $257.49K |
| Avalyn Pharma Inc | 0.07% | $82.30K |
| Alebund Pharmaceuticals Jiangsu Ltd | 0.06% | $72.02K |
| Alamar Biosciences Inc | 0.03% | $35.22K |
| Contra Abiomed, Inc. | 0.00% | $903 |
HIAHX overview: performance, fees, allocation and SEC filings